Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials Sponsored by Gencor Pacific Group
Total 0 results
Nothing found
Sponsors and Collaborators
AMTC & Associates
Rui-hua Xu, MD, PhD
Cardresearch
San MediTech(Huzhou)Co.,Ltd.
The Fifth Affiliated Hospital of Zunyi Medical College
Societa Italiana di Endoscopia Digestiva
Victor Montori
University Medical Center Goettingen
University Centre for Chronic Diseases Dekkerswald, Groesbeek, NL
Caritas Freetown
Donders Institute for Brain, Cognition and Behavior
Fondren Orthopedic Group L.L.P.
Diego Hernan Giunta, MD
ProteoSys AG
Celtaxsys Aus Pty Limited
Norsk Proteinintolerance, Norway
CRMBM-CEMEREM
Alberta Children's Hospital, Calgary, Canada
Ilustre Colegio Profesional de Fisioterapeutas de la Comunidad de Madrid
Elim Pediatric Pharmaceuticals Inc.
View Full List
Medical Conditions
Using Imagery to Maintain Muscle Mass Gains in the Quadriceps
Stage II Vulvar Cancer
Smith-Lemli-Opitz Syndrome
Enlarged Uterus
Airway Obstruction
Raynaud Secondary to Other Autoimmune Disease
Advanced Gastric Cancer With Serosal Invasion
Role of Vitamin D in IVF for Better Outcome
Urinary Tract Carcinoma
Caffeine Dosage
EHMT1
Gait Variability; Elders; Fall; Re-education
Stereotype-threat
Secondary Hypertension to Endocrine Disorders
Pancytopenia Due to Chemotherapy
Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia
Pulmonary Invasive Aspergillosis
High Perinatal Mortality
Global Health
Autologous Haematopoietic Stem Cell Transplant
View Full List
Drug Interventions
HB-202 / HB-201 alternating intravenous administration + standard of care regimen including pembrolizumab.
PF-00868554
Methotrexate
Cytarabine ARA-C
Flibanserin 100 mg dose every evening
Topotecan
Lamivudine
Ruxolitinib
Epimedium Prenylflavonoids Extract
CTx-1301-Dexmethylphenidate 18.75mg (randomized fixed dose)
Bortezomib/dexamethasone
Polyethylene glycol 3350
Insulin
Oxycodone, fentanyl
Mupirocin Calcium
Atezolizumab
Cetrorelix 78 mg + 78 mg
Enzalutamide, Abiraterone
SERETIDE Diskus
Indoximod
View Full List
CROs by country
Contract Research Organizations in Argentina
Contract Research Organizations in Bangladesh
Contract Research Organizations in Brazil
Contract Research Organizations in Bulgaria
Contract Research Organizations in Finland
Contract Research Organizations in Japan
Contract Research Organizations in Kenya
Contract Research Organizations in Kyrgyzstan
Contract Research Organizations in Lebanon
Contract Research Organizations in Lithuania
Contract Research Organizations in Malawi
Contract Research Organizations in Portugal
Contract Research Organizations in Zimbabwe
CRO list by country
CROs in United States
North Carolina Clinical Research (NCCR)
Bracane Company
Sylvana Research
Allphase Clinical Research
X7 Research
Veristat
Bio Analytical Research Corporation (BARC)
BASi
Allucent
Pacific BioLabs
All CROs in United States
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe